Acurx Pharmaceuticals Inc (ACXP)
2.27
+0.11
(+5.09%)
USD |
NASDAQ |
May 17, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Cash and Short Term Investments (Quarterly): 8.921M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.921M |
| December 31, 2023 | 7.474M |
| September 30, 2023 | 7.052M |
| June 30, 2023 | 9.146M |
| March 31, 2023 | 7.179M |
| December 31, 2022 | 9.112M |
| September 30, 2022 | 10.61M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.092M |
| March 31, 2022 | 11.08M |
| December 31, 2021 | 12.96M |
| September 30, 2021 | 14.46M |
| June 30, 2021 | 17.10M |
| March 31, 2021 | 2.628M |
| December 31, 2020 | 3.175M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.628M
Minimum
Mar 2021
17.10M
Maximum
Jun 2021
9.284M
Average
9.102M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 0.524M |
| Tonix Pharmaceuticals Holding Corp | 7.049M |
| PetVivo Holdings Inc | 0.0801M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |